References
- Bassiony MM (2009). Smoking in Saudi Arabia. Saudi Med J. 30, 876-81.
- Bhatti N, Downer M, Bulman JS (1995). Public knowledge and attitudes on oral cancer: a pilot investigation. J Inst Health Educ. 32, 112-7.
- Bhurgri Y (2004). Karachi cancer registry data-implications for the national cancer control program of Pakistan. Asian Pac J Cancer Prev, 5, 77-82.
- Bhurgri Y (2005). Cancer of the oral cavity - trends in Karachi south (1995-2002). Asian Pac J Cancer Prev, 6, 22-6.
- Bhurgri Y, Bhurgri A, Hussainy AS, et al (2003). Cancer of the oral cavity, pharynx in Karachi - Identification of potential risk factors. Asian Pac J Cancer Prev, 4, 125-30.
- Bhurgri Y, Bhurgri A, Usman A, et al (2006). Epidemiological review of head, neck cancers in Karachi. Asian Pac J Cancer Prev, 7, 195-200.
- Brocklehurst P, Kujan O, Glenny AM, et al (2010). Screening programmes for the early detection and prevention of oral cancer. Cochrane Database Syst Rev, 11, 4150.
- Chaudhari A, Hegde-Shetiya S, Shirahatti R, et al (2013). Comparison of different screening methods in estimating the prevalence of precancer and cancer amongst male inmates of a jail in Maharashtra, India. Asian Pac J Cancer Prev, 14, 859-64. https://doi.org/10.7314/APJCP.2013.14.2.859
- Downer MC, Moles DR, Palmer S, Speight PM (2004). A systematic review of test performance in screening for oral cancer and precancer. Oral Oncol, 40, 264-73. https://doi.org/10.1016/j.oraloncology.2003.08.013
- Eaton L (2003). World cancer rates set to double by 2020. BMJ, 326, 728. https://doi.org/10.1136/bmj.326.7392.728
- Epstein JB, Guneri P (2009). The adjunctive role of toluidine blue in detection of oral premalignant and malignant lesions. Curr Opin Otolaryngol Head Neck Surg, 17, 79-87. https://doi.org/10.1097/MOO.0b013e32832771da
- Epstein JB, Oakley C, Millner A, et al (1997). The utility of toluidine blue application as a diagnostic aid in patients previously treated for upper oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 83, 537-47. https://doi.org/10.1016/S1079-2104(97)90117-7
- Farah CS, McCullough MJ (2007). A pilot case control study on the efficacy of acetic acid wash and chemiluminescent illumination (ViziLite) in the visualisation of oral mucosal white lesions. Oral Oncol, 43, 820-4. https://doi.org/10.1016/j.oraloncology.2006.10.005
- Fedele S (2009). Diagnostic aids in the screening of oral cancer. Head Neck Oncol, 1, 5. https://doi.org/10.1186/1758-3284-1-5
- Gray MGL, Burls A, Elley K (2000). The clinical effectiveness of toluidine blue dye as an adjunct to oral cancer screening in general dental practice. A West Midlands Development and Evaluation Service Report.
- IARC-WHO (2002). World Cancer Report. Edited by: Stewart BW, Kleihues P. International Agency for reseacrh on Cancer and World Health organization. Geneve: Suisse.
- Johnson NW, Warnakulasuriya S, Gupta PC, et al (2011). Global oral health inequalities in incidence and outcomes for oral cancer: causes and solutions. Adv Dent Res, 23, 237-46. https://doi.org/10.1177/0022034511402082
- Kujan O, Sloan P (2013). Dilemmas of oral cancer screening: an update. Asian Pac J Cancer Prev, 14, 3369-73. https://doi.org/10.7314/APJCP.2013.14.5.3369
- Lingen MW, Kalmar JR, Karrison T, Speight PM (2008). Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol, 44, 10-22. https://doi.org/10.1016/j.oraloncology.2007.06.011
- Mashberg A (1980). Reevaluation of toluidine blue application as a diagnostic adjunct in the detection of asymptomatic oral squamous carcinoma: a continuing prospective study of oral cancer III. Cancer. 46, 758-63. https://doi.org/10.1002/1097-0142(19800815)46:4<758::AID-CNCR2820460420>3.0.CO;2-8
- Mashberg A, Feldman LJ (1988). Clinical criteria for identifying early oral and oropharyngeal carcinoma: erythroplasia revisited. Am J Surg, 156, 273-5. https://doi.org/10.1016/S0002-9610(88)80290-3
- McIntosh L, McCullough MJ, Farah CS (2009). The assessment of diffused light illumination and acetic acid rinse (Microlux/DL) in the visualisation of oral mucosal lesions. Oral Oncol, 45, 227-31. https://doi.org/10.1016/j.oraloncology.2009.08.001
- Messadi DV (2013). Diagnostic aids for detection of oral precancerous conditions. Int J Oral Sci, 5, 59-65. https://doi.org/10.1038/ijos.2013.24
- Mehrotra R, Gupta DK (2011). Exciting new advances in oral cancer diagnosis: avenues to early detection. Head Neck Oncol, 3, 33. https://doi.org/10.1186/1758-3284-3-33
- Myers EN (1970). The toluidine blue test in lesions of the oral cavity. CA Cancer J Clin, 20, 134-9. https://doi.org/10.3322/canjclin.20.3.134
- Nagaraju K, Prasad S, Ashok L (2010). Diagnostic efficiency of toluidine blue with lugol's iodine in oral premalignant and malignant lesions. Ind J Dent Res, 21, 218-2. https://doi.org/10.4103/0970-9290.66633
- Patton LL, Epstein JB, Kerr AR (2008). Adjunctive techniques for oral cancer examination and lesion diagnosis: a systematic review of the literature. J Am Dent Assoc, 139, 896-905. https://doi.org/10.14219/jada.archive.2008.0276
- Ram S, Siar CH (2005). Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions. Int J Oral Maxillofac Surg, 34, 521-7. https://doi.org/10.1016/j.ijom.2004.10.008
- Rao K, Mejia G, Roberts-Thompson K, Logan R (2013) Epidemiology of oral cancer in Asia in the past decade--an update (2000-2012). Asian Pac J Cancer Prev, 14, 5567-77. https://doi.org/10.7314/APJCP.2013.14.10.5567
- Rethman MP, Carpenter W, Cohen EE, et al (2010). Evidencebased clinical recommendations regarding screening for oral squamous cell carcinomas. J Am Dent Assoc, 141, 509-20. https://doi.org/10.14219/jada.archive.2010.0223
- Sankaranarayanan R, Ramadas K, Thara S, et al (2013). Long term effect of visual screening on oral cancer incidence and mortality in a randomized trial in Kerala, India. Oral Oncol, 49, 314-21. https://doi.org/10.1016/j.oraloncology.2012.11.004
- Seoane J, Diz P (2010). Diagnostic clinical aids in oral cancer. Oral Oncol, 46, 418-22. https://doi.org/10.1016/j.oraloncology.2010.03.006
- Seoane-Romero JM, Vazquez-Mahia I, Seoane J, et al (2011). Factors related to late stage diagnosis of oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal, 17, 35-40.
- Siegel R, Naishadham D, Jemal A (2012). Cancer statistics. CA Cancer J Clin, 62, 10-29. https://doi.org/10.3322/caac.20138
- Sunny L, Yeole BB, Hakama M, et al (2004). Oral cancers in Mumbai, India: a fifteen years perspective with respect to incidence trend, cumulative risk. Asian Pac J Cancer Prev, 5, 294-300.
- Talole BS, Patki MB (2006). Prevalence of oral precancerous lesions in tobacco of Naigaon, Mumbai. Indian J Community Medicine, 31, 286.
- Warnakulasuriya S, Johnson NW, Van der Waal I (2007). Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med, 36, 575-80. https://doi.org/10.1111/j.1600-0714.2007.00582.x
- Wilson JM, Jungner YG (1968). Principles and practice of mass screening for disease. Bol Oficina Sanit Panam, 65, 281-393.
Cited by
- Non-Invasive Techniques for Detection and Diagnosis of Oral Potentially Malignant Disorders vol.238, pp.2, 2016, https://doi.org/10.1620/tjem.238.165
- An Overview on Current Non-invasive Diagnostic Devices in Oral Oncology vol.9, pp.1664-042X, 2018, https://doi.org/10.3389/fphys.2018.01510